𝔖 Bobbio Scriptorium
✦   LIBER   ✦

LB 80380 promising in lamivudine-resistant HBV

Book ID
120851974
Publisher
Adis International Limited (now part of Wolters Kluwer Health)
Year
2006
Weight
133 KB
Volume
&NA;
Category
Article
ISSN
1173-8324

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Antiviral activity and safety of LB80380
Antiviral activity and safety of LB80380 in hepatitis B e antigen–positive chronic hepatitis B patients with lamivudine-resistant disease
✍ Man-Fung Yuen; Kwang-Hyub Han; Soon-Ho Um; Seung Kew Yoon; Hye-Ryon Kim; John Ki πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 380 KB πŸ‘ 1 views

We aimed to determine the antiviral activity and safety of a new nucleotide analogue, LB80380, in chronic hepatitis B (CHB) patients with lamivudine-resistant virus. Sixty-five patients with lamivudine-resistant virus were randomized to receive five ascending daily doses (30, 60, 90, 150, 240 mg) of